Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants
Sponsor: Eli Lilly and Company
Summary
The main purpose of this study is to determine the levels of study drug called LY3502970 in the blood stream when administered alone and in combination with clarithromycin in healthy participants. This study will last up to approximately 85 days for each participant.
Official title: A Phase 1, Open-label, Drug Interaction Study to Investigate the Effect of Multiple Doses of Clarithromycin on the Pharmacokinetics of LY3502970 in Healthy Participants
Key Details
Gender
All
Age Range
21 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
26
Start Date
2022-08-01
Completion Date
2022-11-03
Last Updated
2026-05-27
Healthy Volunteers
Yes
Conditions
Interventions
LY3502970
Administered orally.
Clarithromycin
Administered orally.
Locations (1)
Lilly Centre for Clinical Pharmacology
Singapore, Singapore